Prim, S.A. (BME:PRM)
13.85
+0.10 (0.73%)
Oct 28, 2025, 5:35 PM CET
Prim, S.A. Revenue
Prim, S.A. had revenue of 127.01M EUR in the half year ending June 30, 2025, with 16.80% growth. This brings the company's revenue in the last twelve months to 240.68M, up 5.76% year-over-year. In the year 2024, Prim, S.A. had annual revenue of 233.36M with 7.73% growth.
Revenue (ttm)
240.68M
Revenue Growth
+5.76%
P/S Ratio
0.97
Revenue / Employee
266.83K
Employees
958
Market Cap
233.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 233.36M | 16.74M | 7.73% |
| Dec 31, 2023 | 216.62M | 19.22M | 9.74% |
| Dec 31, 2022 | 197.40M | 28.82M | 17.10% |
| Dec 31, 2021 | 168.57M | 21.16M | 14.35% |
| Dec 31, 2020 | 147.41M | -3.66M | -2.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.45B |
| Almirall | 1.05B |
| Laboratorios Farmaceuticos Rovi | 749.00M |
| Faes Farma | 543.77M |
| Laboratorio Reig Jofre | 336.87M |
| Clínica Baviera | 288.92M |
| Atrys Health | 226.24M |
| Pharma Mar | 189.27M |